EA200970944A1 - Применение биполярных транскаротиноидов в качестве предварительного лечения при лечении заболевания периферических сосудов - Google Patents

Применение биполярных транскаротиноидов в качестве предварительного лечения при лечении заболевания периферических сосудов

Info

Publication number
EA200970944A1
EA200970944A1 EA200970944A EA200970944A EA200970944A1 EA 200970944 A1 EA200970944 A1 EA 200970944A1 EA 200970944 A EA200970944 A EA 200970944A EA 200970944 A EA200970944 A EA 200970944A EA 200970944 A1 EA200970944 A1 EA 200970944A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
transcarotinoids
bipolar
application
peripheral vessel
Prior art date
Application number
EA200970944A
Other languages
English (en)
Inventor
Джон Л. Гейнер
Original Assignee
Диффьюжн Фармасьютикалз Ллс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Диффьюжн Фармасьютикалз Ллс filed Critical Диффьюжн Фармасьютикалз Ллс
Publication of EA200970944A1 publication Critical patent/EA200970944A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Настоящая заявка относится к способам лечения заболевания периферических сосудов (PVD), а также ишемического остеонекроза, перитонеальной ишемии, хронического заболевания глаз, дегенерации желтого пятна или диабетической ретинопатии, включающим введение терапевтически эффективного количества транскаротиноида. Настоящее изобретение также относится к применению таких каротиноидов в качестве средств предварительной обработки для млекопитающих с риском ишемического эпизода.
EA200970944A 2007-04-13 2008-04-11 Применение биполярных транскаротиноидов в качестве предварительного лечения при лечении заболевания периферических сосудов EA200970944A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90771807P 2007-04-13 2007-04-13
PCT/US2008/004708 WO2008136900A1 (en) 2007-04-13 2008-04-11 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease

Publications (1)

Publication Number Publication Date
EA200970944A1 true EA200970944A1 (ru) 2010-06-30

Family

ID=39854321

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200970944A EA200970944A1 (ru) 2007-04-13 2008-04-11 Применение биполярных транскаротиноидов в качестве предварительного лечения при лечении заболевания периферических сосудов

Country Status (13)

Country Link
US (2) US8293804B2 (ru)
EP (3) EP2146948A4 (ru)
JP (2) JP2010524855A (ru)
KR (1) KR101570131B1 (ru)
CN (1) CN101687757A (ru)
AU (1) AU2008246305B2 (ru)
BR (1) BRPI0810647A2 (ru)
CA (1) CA2683760C (ru)
EA (1) EA200970944A1 (ru)
IL (1) IL201438A (ru)
MX (1) MX2009010988A (ru)
WO (1) WO2008136900A1 (ru)
ZA (1) ZA200907757B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL163685A0 (en) * 2002-02-25 2005-12-18 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
CA2598882C (en) * 2005-02-24 2020-02-25 Diffusion Pharmaceuticals Llc Trans carotenoids, their synthesis, formulation and uses
KR101570131B1 (ko) 2007-04-13 2015-11-18 디퓨젼 파마슈티컬즈 엘엘씨 양극성 트랜스 카로티노이드의 말초혈관질환 치료와 예방을 위한 용도
EA201070544A1 (ru) * 2007-10-31 2010-12-30 Диффьюжн Фармасьютикалз Ллс Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений
CN108464976A (zh) * 2009-06-22 2018-08-31 扩散药品有限公司 扩散促进化合物及其单独或与溶栓药一起的应用
US8974822B2 (en) * 2010-06-02 2015-03-10 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
GB201120772D0 (en) * 2011-12-02 2012-01-11 Ip Science Ltd Cocoa-based food products
KR102489034B1 (ko) 2016-03-24 2023-01-13 디퓨젼 파마슈티컬즈 엘엘씨 암을 치료하기 위한, 화학 요법 및 방사선 요법과의 양극성 트랜스 카로티노이드의 용도
CN108403677B (zh) * 2018-05-03 2020-06-05 北京市心肺血管疾病研究所 藏红花素在预防和治疗胸主动脉夹层/主动脉瘤中的应用
EP3829469A4 (en) * 2018-07-30 2022-04-27 Diffusion Pharmaceuticals LLC DIFFUSION ENHANCING COMPOUNDS AND THEIR USE IN THROMBECTOMY AND EMBOLICTOMY AND OTHER VASCULAR DISEASE PROCEDURES
WO2023081779A1 (en) * 2021-11-03 2023-05-11 Diffusion Pharmaceuticals Llc Crystalline forms of a diffusion enhancing compound

Family Cites Families (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2948748A (en) * 1960-08-09 Esters thereof
US2175843A (en) * 1936-06-26 1939-10-10 Winthrop Chem Co Inc Polyene carboxylic acids and esters and manufacture thereof
CH468330A (de) * 1966-01-28 1969-02-15 Hoffmann La Roche Verfahren zur Herstellung von isoprenoiden Verbindungen
US3489806A (en) 1967-01-19 1970-01-13 Hoffmann La Roche Isoprenoid compounds and a process for producing the same
US3489809A (en) * 1968-04-17 1970-01-13 Engelhard Min & Chem Selective hydrogenation with a catalyst on a honeycomb support
JPS4514114Y1 (ru) 1969-07-17 1970-06-15
CH522572A (de) 1969-10-31 1972-06-30 Hoffmann La Roche Verfahren zur Herstellung von Polyenverbindungen
US3788468A (en) * 1973-05-01 1974-01-29 Univ Virginia Process for increasing oxygen diffusivity
US3853993A (en) * 1973-05-01 1974-12-10 Univ Virginia Process for increasing oxygen diffusivity and method for treating atherosclerosis
DE2505869C3 (de) * 1975-02-12 1978-05-18 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von symmetrischen Carotinoiden
US3965261A (en) * 1975-04-29 1976-06-22 University Of Virginia Method for treating papillomas
US3975519A (en) * 1975-06-09 1976-08-17 University Of Virginia Method for increasing the oxygen partial pressure in the bloodstream of mammals
US4070460A (en) * 1975-11-10 1978-01-24 University Of Virginia Patents Foundation Method for treating cerebral edema
US4009270A (en) * 1975-11-21 1977-02-22 The University Of Virginia Method for treating spinal cord injury
US4038144A (en) * 1976-04-19 1977-07-26 The University Of Virginia Method of increasing fermentation yields
US4046880A (en) * 1976-04-20 1977-09-06 The University Of Virginia Method of treating hypertension
US4099270A (en) * 1977-02-16 1978-07-11 Jabour Richard J Slip-on rubber gloves
US4216211A (en) * 1977-10-31 1980-08-05 The Procter & Gamble Company Therapeutic composition
US4176179A (en) * 1978-04-17 1979-11-27 The University Of Virginia Alumni Patents Foundation Method for treating arthritis
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
US4699664A (en) 1985-05-01 1987-10-13 Nestec S.A. Stabilized natural pigment complexes
US5032613A (en) 1986-02-12 1991-07-16 W. Keith R. Watson Method and composition for treating arthritis
JPH0661211B2 (ja) 1986-08-29 1994-08-17 花王株式会社 パン用改質剤、パン生地及びパンの製造方法
US4781676A (en) 1987-02-20 1988-11-01 Air Products And Chemicals, Inc. Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells
US5811119A (en) * 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
US5084274A (en) 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
US5472946A (en) * 1988-04-08 1995-12-05 Peck; James V. Transdermal penetration enhancers
GB8822147D0 (en) 1988-09-21 1988-10-26 Ciba Geigy Ag Pharmaceutically active combination
FR2647343B1 (fr) 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
IT1233303B (it) 1989-06-07 1992-03-26 Azionaria Costruzioni Acma Spa Apparecchiatura per il convogliamento di prodotti
US5053240A (en) * 1989-10-24 1991-10-01 Kalamazoo Holdings, Inc. Norbixin adducts with water-soluble or water-dispersible proteins or branched-chain or cyclic polysaccharides
JPH04264020A (ja) 1991-02-18 1992-09-18 Yamanouchi Pharmaceut Co Ltd 安定な凍結乾燥製剤
US5107030A (en) 1991-03-04 1992-04-21 Loyola University Of Chicago Method of making 2,7-dimethyl-2,4,6-octatrienedial and derivatives thereof
JP3176716B2 (ja) 1991-06-21 2001-06-18 武田薬品工業株式会社 溶解性が向上した難水溶性薬物組成物
JP2977961B2 (ja) 1991-07-26 1999-11-15 株式会社資生堂 化粧料
JPH06248193A (ja) 1993-02-25 1994-09-06 Ensuiko Sugar Refining Co Ltd クロセチン含有着色料
IL110139A0 (en) 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
JPH0723736A (ja) 1993-06-30 1995-01-27 Taishiyoo Technos:Kk カロチノイド色素の可溶化方法
JP2704356B2 (ja) 1994-02-08 1998-01-26 正和薬品株式会社 脳機能改善剤
JPH07291854A (ja) 1994-04-26 1995-11-07 Tanabe Seiyaku Co Ltd 溶解性の改善された医薬品製剤
US5576287A (en) 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
GB2290964A (en) 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
US6060511A (en) 1995-10-05 2000-05-09 Gainer; John L. Trans-sodium crocetinate, methods of making and methods of use thereof
US5800807A (en) 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
RU2107496C1 (ru) 1997-02-10 1998-03-27 Российская медицинская академия последипломного образования Министерства здравоохранения РФ Способ лечения диабетической ангиопатии
JPH1129466A (ja) 1997-07-09 1999-02-02 Lion Corp 水性皮膚外用剤
US6391336B1 (en) 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
US6150561A (en) 1997-10-03 2000-11-21 Roche Vitamins Inc. Method of making carotenoids
JPH11209642A (ja) 1998-01-27 1999-08-03 Taito Kk アナトー色素製剤及びその製造方法
JP2000007570A (ja) 1998-06-24 2000-01-11 Hayashibara Biochem Lab Inc 抗内分泌障害剤
MA25590A1 (fr) 1998-09-14 2002-12-31 Inhale Therapeutic Syst Agent actif de delivraison de poudre seche
BE1012495A3 (fr) 1999-03-02 2000-11-07 Messadek Jallal La glycine-betaine pour son usage antithrombotique.
GB2353934A (en) 1999-09-09 2001-03-14 British Sugar Plc Nutritional compositions comprising trehalose for persons suffering from diabetes
CA2355814C (en) * 2000-09-14 2010-06-29 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition for ophthalmic use
EP1269994A3 (en) 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
JP2003201238A (ja) 2001-12-03 2003-07-18 Yamanouchi Pharmaceut Co Ltd 脳梗塞治療用医薬組成物
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
IL163685A0 (en) 2002-02-25 2005-12-18 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US20030180282A1 (en) * 2002-03-25 2003-09-25 Victor Serebruany Method of treatment of thrombotic events
RU2226096C1 (ru) 2002-07-01 2004-03-27 Санкт-Петербургский государственный научно-исследовательский институт скорой помощи им. И.И.Джанелидзе Способ лечения последствий тканевой гипоксии у пациентов в критическом состоянии
US7521584B2 (en) 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
AU2003256982A1 (en) 2002-07-29 2004-02-16 Cardax Pharmaceuticals, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
US7084423B2 (en) 2002-08-12 2006-08-01 Acorn Technologies, Inc. Method for depinning the Fermi level of a semiconductor at an electrical junction and devices incorporating such junctions
AU2002343174A1 (en) 2002-11-25 2004-06-18 Rachid Ennamany Betaine and salicylic acid compositions
US20040109920A1 (en) * 2002-12-04 2004-06-10 Bioactives Llc Coated carotenoid cyclodextrin complexes
US20070166339A1 (en) 2003-04-18 2007-07-19 Bioderm Research Skin Whitening Methods and Compositions Based on Zeolite - Active Oxygen Donor Complexes
CA2524573A1 (en) 2003-05-02 2004-11-11 Paion Deutschland Gmbh Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke
JP2005053841A (ja) 2003-08-05 2005-03-03 Kyouto Biomedical Science:Kk 皮膚外用剤
AU2003265617A1 (en) 2003-08-25 2005-04-11 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
RU2265434C2 (ru) 2003-09-30 2005-12-10 Государственное учреждение Научно-исследовательский Институт Общей реаниматологии Российской Академии Медицинских Наук (ГУ НИИ ОР РАМН) Способ лечения острого респираторного дистресс-синдрома
RU2256446C1 (ru) 2003-10-22 2005-07-20 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова Способ профилактики метастазов после хирургического удаления внутриглазных новообразований
US7446101B1 (en) * 2003-12-12 2008-11-04 Bioactives, Llc Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems
RU2007101074A (ru) 2004-06-14 2008-07-20 Зозер Б. САЛАМА (DE) Фармацевтическая противораковая композиция пролина или его производных и противоопухолевого антитела
JP4514114B2 (ja) 2004-06-18 2010-07-28 ヤマハ発動機株式会社 コイル可動形リニアモータおよび単軸ロボット
CA2581764A1 (en) 2004-09-27 2006-04-06 Sigmoid Biotechnologies Limited Minicapsule formulations
US20090176287A1 (en) 2005-02-24 2009-07-09 Regents Of The University Of Minnesota Producing carotenoids
CA2598882C (en) * 2005-02-24 2020-02-25 Diffusion Pharmaceuticals Llc Trans carotenoids, their synthesis, formulation and uses
EP2329825B1 (en) * 2005-03-04 2015-10-07 Sucampo AG Method and composition for treating peripheral vascular diseases
EP1861109A2 (en) 2005-03-09 2007-12-05 Cardax Pharmaceuticals, Inc. Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders
US20060281724A1 (en) 2005-06-08 2006-12-14 Loria Roger M Methods for Treating Shock
JP2006342108A (ja) 2005-06-09 2006-12-21 Mitsubishi Chemicals Corp アミロスフェロイドにより発生する疾患の予防治療剤
WO2007028167A2 (en) * 2005-09-02 2007-03-08 Iomai Corporation Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs and uses thereof
US20070135521A1 (en) 2005-12-14 2007-06-14 Yamaha Hatsudoki Kabushiki Kaisha Agent for Preventing Metabolic Syndrome
AU2006341188A1 (en) 2006-03-24 2007-10-04 Ian Simon Tracton Stable packaged dosage form and process therefor
CN100571707C (zh) 2006-07-24 2009-12-23 凌沛学 含有海藻糖的关节腔内注射给药制剂
CA2661012C (en) 2006-08-29 2019-03-19 Genentech, Inc. Method of treating stroke with thrombolytic agent
EP2198869B1 (en) 2007-02-23 2015-09-16 Next 21 K.K. Trehalose for the treatment or prevention of vasospasm
KR101570131B1 (ko) 2007-04-13 2015-11-18 디퓨젼 파마슈티컬즈 엘엘씨 양극성 트랜스 카로티노이드의 말초혈관질환 치료와 예방을 위한 용도
SI2152250T1 (sl) 2007-05-07 2020-06-30 Evonik Operations Gmbh Trdne dozirne oblike, ki vsebujejo enterično oplaščenje s pospešenim sproščanjem zdravila
EA201070544A1 (ru) 2007-10-31 2010-12-30 Диффьюжн Фармасьютикалз Ллс Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений
US20090118227A1 (en) 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20110003892A1 (en) 2008-03-06 2011-01-06 Margaret Clagett-Dame All-trans retinoid esters as active pharmaceutical ingredients, oral and topical dosage form compositions thereof, and methods of treating skin conditions thereof
JP2009274988A (ja) 2008-05-14 2009-11-26 Mitsubishi Rayon Co Ltd ヒドロキシアルキル（メタ）アクリレート類の製造方法
JP2010110185A (ja) 2008-10-31 2010-05-13 Toshiba Corp 電子装置およびファンの制御方法
US8974822B2 (en) 2010-06-02 2015-03-10 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
US10340357B2 (en) 2017-09-25 2019-07-02 Taiwan Semiconductor Manufacturing Co., Ltd. Dishing prevention dummy structures for semiconductor devices

Also Published As

Publication number Publication date
IL201438A0 (en) 2010-05-31
AU2008246305A1 (en) 2008-11-13
CN101687757A (zh) 2010-03-31
AU2008246305B2 (en) 2013-03-21
KR20100016396A (ko) 2010-02-12
WO2008136900A1 (en) 2008-11-13
EP2146948A1 (en) 2010-01-27
CA2683760C (en) 2015-05-19
KR101570131B1 (ko) 2015-11-18
EP2589588A1 (en) 2013-05-08
IL201438A (en) 2015-03-31
ZA200907757B (en) 2012-04-25
MX2009010988A (es) 2010-03-15
JP2010524855A (ja) 2010-07-22
US20120035256A1 (en) 2012-02-09
EP3483140A1 (en) 2019-05-15
US20080255246A1 (en) 2008-10-16
US8901174B2 (en) 2014-12-02
US8293804B2 (en) 2012-10-23
BRPI0810647A2 (pt) 2014-11-04
CA2683760A1 (en) 2008-11-13
JP2014139221A (ja) 2014-07-31
EP2146948A4 (en) 2010-08-04

Similar Documents

Publication Publication Date Title
EA200970944A1 (ru) Применение биполярных транскаротиноидов в качестве предварительного лечения при лечении заболевания периферических сосудов
BR112014027571A2 (pt) métodos para o tratamento de retinopatia diabética e outras doenças oftalmológicas
BR112014008759A2 (pt) tratamento de doença ocular
EA201591176A1 (ru) Композиции и способы с использованием пептидной метки, связывающейся с гиалуронаном
SG191334A1 (en) Use of a vegf antagonist to treat angiogenic eye disorders
EA201390826A1 (ru) ПИРИМИДИНОНОВЫЕ СОЕДИНЕНИЯ ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ИЛИ СОСТОЯНИЙ, ОПОСРЕДОВАННЫХ Lp-PLA
MY189333A (en) Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viii
EA201490254A1 (ru) Комбинированное лечение гепатита с
EA201391315A1 (ru) Гуанидиновое соединение
MY178654A (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig protein scaffold for use in therapy
EA201490721A1 (ru) Лекарственное средство для лечения заболеваний передней камеры глаза, включающее ребамипид и агент, удерживающий слезы
EA201490941A1 (ru) Модуляторы mas рецептора, сопряженного с g-белком, и лечение связанных с ним расстройств
EA201291167A1 (ru) Замещенные гетероциклилбензилпиразолы и их применение
EA201100462A1 (ru) Серосвязанные соединения для лечения офтальмологических заболеваний и расстройств
EA201491369A1 (ru) Способ лечения сахарного диабета при помощи негликозилированного аполипопротеина a-iv
EA201790563A1 (ru) Применение реслизумаба для лечения эозинофильной астмы со степенью тяжести от умеренной до тяжелой
EA201892536A1 (ru) Фармацевтические носители, содержащие микрорнк, для применения в лечении фиброзных заболеваний, вызванных гипергликемией
MX2011012310A (es) Tratamiento de insuficiencia cardiaca con fracción de eyeccion normal (icfen).
EA200970127A1 (ru) Модулятор рецепторов глюкокортикостероидов и способы его применения
EP4245295A3 (en) Compounds and pharmaceutical compositions for use in treating retina-associated disease using ccr3-inhibitors
EA201391063A1 (ru) Аполипопротеин a-iv в качестве антидиабетического пептида
EP2106260A4 (en) INSULIN SENSITIZERS AND TREATMENT PROCEDURES THEREWITH
EA201591123A1 (ru) Комбинации агониста glp1r и метформина, а также способ их применения при лечении диабета 2 типа и прочих расстройств
WO2020142740A8 (en) Treatment of sjogren's disease with nuclease fusion proteins
RU2013104381A (ru) Лечение отслойки васкуляризированного пигментного эпителия терапевтическим средством против vegf